Skip to content

Clinical trial of Yiqing capsule combined with adapalene gel in the treatment of acne vulgaris

Clinical trial of Yiqing capsule combined with adapalene gel in the treatment of acne vulgaris

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054470
Enrollment
Unknown
Registered
2021-12-18
Start date
2021-12-18
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Control group:Apply adapalene gel at bedtime
Experimental group:Adapalene gel before bedtime + Yiqing capsule

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for acne; 2. The skin lesions are mainly located on the face; 3. In line with TCM classification and syndrome differentiation; 4. Aged 18 to 40 years, gender is not limited; 5. The course of disease exceeds 6 months; 6. The patient signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Drug-induced acne, occupational acne, delayed acne, and explosive acne; 2. Have used antibiotics and tretinoin preparations in the past 4 weeks, and have used hormone drugs in the past 8 weeks; 3. Patients with severe liver and kidney dysfunction, cardiopulmonary insufficiency, and serious diseases of the digestive tract and blood system; 4. Severe allergic constitution, allergic to known drugs in the study or contraindicated; 5. Patients with mental illness, tumor disease and immunodeficiency; 6. Those who use other therapies in the same period, which affect the judgment of curative effect.

Design outcomes

Primary

MeasureTime frame
Acne Comprehensive Grading System Score;

Secondary

MeasureTime frame
Cardiff Acne Index;Dermatology Quality of Life Index;TCM Symptom Score Scale;Testosterone;Estradiol;Interleukin;Intestinal flora;

Countries

China

Contacts

Public ContactWang Linyuan

Beijing University of Chinese Medicine

wanglinyuan110@vip.163.com+86 13381002202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026